Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Launched by NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) · Apr 19, 2006
Trial Information
Current as of March 21, 2025
Completed
Keywords
ClinConnect Summary
This protocol has three purposes:
1. to evaluate non-treatment seeking participants for inclusion or exclusion from other NIAAA protocols. Non-treatment seeking participants includes individuals with no current or past alcohol use disorder, as well as individuals who meet the DSM IV criteria for alcohol abuse or alcohol dependence (alcohol use disorders (AUD) but are not seeking treatment;
2. to provide a common set of descriptive information that will be available on all NIAAA research participants;
3. to collect blood samples from participants for the purpose of genetic analyses
Informa...
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- • 1. In good health.
- • 2. Over 18 years of age.
- • 3. Not seeking treatment for alcohol or other drug use.
- EXCLUSION CRITERIA:
- • 1) Serious medical conditions that require ongoing treatment.
Trial Officials
Reza Momenan, Ph.D.
Principal Investigator
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
About National Institute On Alcohol Abuse And Alcoholism (Niaaa)
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is a leading federal agency dedicated to advancing research on alcohol-related health issues and fostering a deeper understanding of alcohol use disorders. As part of the National Institutes of Health (NIH), NIAAA supports a diverse portfolio of clinical trials aimed at developing innovative prevention and treatment strategies for alcohol abuse and dependence. By collaborating with researchers, healthcare providers, and community organizations, NIAAA strives to translate scientific findings into effective public health initiatives, ultimately aiming to reduce the impact of alcohol on individuals and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials